List of Tables
    Table 1. Rheumatoid Arthritis Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Rheumatoid Arthritis Drugs Market Trends
    Table 3. Rheumatoid Arthritis Drugs Market Drivers
    Table 4. Rheumatoid Arthritis Drugs Market Challenges
    Table 5. Rheumatoid Arthritis Drugs Market Restraints
    Table 6. Global Rheumatoid Arthritis Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Rheumatoid Arthritis Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Rheumatoid Arthritis Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Rheumatoid Arthritis Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Rheumatoid Arthritis Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Rheumatoid Arthritis Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Rheumatoid Arthritis Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Rheumatoid Arthritis Drugs Sales by Manufacturer, (MT), 2017-2022
    Table 14. Global Rheumatoid Arthritis Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Rheumatoid Arthritis Drugs Price by Manufacturer (2017-2022) & (USD/Kg)
    Table 16. Global Rheumatoid Arthritis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Rheumatoid Arthritis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Drugs as of 2021)
    Table 18. Top Players of Rheumatoid Arthritis Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Rheumatoid Arthritis Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Rheumatoid Arthritis Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Rheumatoid Arthritis Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Rheumatoid Arthritis Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Rheumatoid Arthritis Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Rheumatoid Arthritis Drugs Sales by Players, (MT), 2020, 2021 & 2022
    Table 26. United States Rheumatoid Arthritis Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Rheumatoid Arthritis Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Rheumatoid Arthritis Drugs Sales in Volume by Region (2017-2022) & (MT)
    Table 29. Global Rheumatoid Arthritis Drugs Sales in Volume Forecast by Region (2023-2028) & (MT)
    Table 30. Global Rheumatoid Arthritis Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Rheumatoid Arthritis Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Rheumatoid Arthritis Drugs Sales in Volume by Country (2017-2028) & (MT)
    Table 33. North America Rheumatoid Arthritis Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Rheumatoid Arthritis Drugs Sales in Volume by Region (2017-2028) & (MT)
    Table 35. Asia Pacific Rheumatoid Arthritis Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Rheumatoid Arthritis Drugs Sales in Volume by Country (2017-2028) & (MT)
    Table 37. Europe Rheumatoid Arthritis Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Rheumatoid Arthritis Drugs Sales in Volume by Country (2017-2028) & (MT)
    Table 39. Latin Americaa Rheumatoid Arthritis Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Rheumatoid Arthritis Drugs Sales in Volume by Country (2017-2028) & (MT)
    Table 41. Middle East and Africa Rheumatoid Arthritis Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. AbbVie Corporation Information
    Table 43. AbbVie Description and Business Overview
    Table 44. AbbVie Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 45. AbbVie Rheumatoid Arthritis Drugs Product
    Table 46. AbbVie Recent Development
    Table 47. Amgen Corporation Information
    Table 48. Amgen Description and Business Overview
    Table 49. Amgen Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 50. Amgen Product
    Table 51. Amgen Recent Development
    Table 52. Bayer Corporation Information
    Table 53. Bayer Description and Business Overview
    Table 54. Bayer Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 55. Bayer Product
    Table 56. Bayer Recent Development
    Table 57. Biogen Corporation Information
    Table 58. Biogen Description and Business Overview
    Table 59. Biogen Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 60. Biogen Product
    Table 61. Biogen Recent Development
    Table 62. Boehringer Ingelheim Corporation Information
    Table 63. Boehringer Ingelheim Description and Business Overview
    Table 64. Boehringer Ingelheim Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 65. Boehringer Ingelheim Product
    Table 66. Boehringer Ingelheim Recent Development
    Table 67. Bristol-Myers Squibb Corporation Information
    Table 68. Bristol-Myers Squibb Description and Business Overview
    Table 69. Bristol-Myers Squibb Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 70. Bristol-Myers Squibb Product
    Table 71. Bristol-Myers Squibb Recent Development
    Table 72. F. Hoffmann-La Roche Corporation Information
    Table 73. F. Hoffmann-La Roche Description and Business Overview
    Table 74. F. Hoffmann-La Roche Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 75. F. Hoffmann-La Roche Product
    Table 76. F. Hoffmann-La Roche Recent Development
    Table 77. Johnson and Johnson Corporation Information
    Table 78. Johnson and Johnson Description and Business Overview
    Table 79. Johnson and Johnson Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 80. Johnson and Johnson Product
    Table 81. Johnson and Johnson Recent Development
    Table 82. Merck Corporation Information
    Table 83. Merck Description and Business Overview
    Table 84. Merck Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 85. Merck Product
    Table 86. Merck Recent Development
    Table 87. Mitsubishi Tanabe Pharma Corporation Information
    Table 88. Mitsubishi Tanabe Pharma Description and Business Overview
    Table 89. Mitsubishi Tanabe Pharma Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 90. Mitsubishi Tanabe Pharma Product
    Table 91. Mitsubishi Tanabe Pharma Recent Development
    Table 92. Novartis Corporation Information
    Table 93. Novartis Description and Business Overview
    Table 94. Novartis Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 95. Novartis Product
    Table 96. Novartis Recent Development
    Table 97. Pfizer Corporation Information
    Table 98. Pfizer Description and Business Overview
    Table 99. Pfizer Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 100. Pfizer Product
    Table 101. Pfizer Recent Development
    Table 102. UCB S.A Corporation Information
    Table 103. UCB S.A Description and Business Overview
    Table 104. UCB S.A Rheumatoid Arthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 105. UCB S.A Product
    Table 106. UCB S.A Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Rheumatoid Arthritis Drugs Customers List
    Table 110. Rheumatoid Arthritis Drugs Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Rheumatoid Arthritis Drugs Product Picture
    Figure 2. Global Rheumatoid Arthritis Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Rheumatoid Arthritis Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Rheumatoid Arthritis Drugs Sales 2017-2028 (MT)
    Figure 5. United States Rheumatoid Arthritis Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Rheumatoid Arthritis Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Rheumatoid Arthritis Drugs Sales 2017-2028 (MT)
    Figure 8. United States Rheumatoid Arthritis Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Rheumatoid Arthritis Drugs Market Share in Global, in Volume (MT) 2017-2028
    Figure 10. Rheumatoid Arthritis Drugs Report Years Considered
    Figure 11. Product Picture of Prescription Drugs
    Figure 12. Product Picture of Over-the-counter Drugs
    Figure 13. Global Rheumatoid Arthritis Drugs Market Share by Type in 2022 & 2028
    Figure 14. Global Rheumatoid Arthritis Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Rheumatoid Arthritis Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Rheumatoid Arthritis Drugs Sales by Type (2017-2028) & (MT)
    Figure 17. Global Rheumatoid Arthritis Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Rheumatoid Arthritis Drugs Price by Type (2017-2028) & (USD/Kg)
    Figure 19. United States Rheumatoid Arthritis Drugs Market Share by Type in 2022 & 2028
    Figure 20. United States Rheumatoid Arthritis Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Rheumatoid Arthritis Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Rheumatoid Arthritis Drugs Sales by Type (2017-2028) & (MT)
    Figure 23. United States Rheumatoid Arthritis Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Rheumatoid Arthritis Drugs Price by Type (2017-2028) & (USD/Kg)
    Figure 25. Product Picture of Hospital
    Figure 26. Product Picture of Clinic
    Figure 27. Product Picture of Nursing Home
    Figure 28. Product Picture of Other
    Figure 29. Global Rheumatoid Arthritis Drugs Market Share by Application in 2022 & 2028
    Figure 30. Global Rheumatoid Arthritis Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Rheumatoid Arthritis Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Rheumatoid Arthritis Drugs Sales by Application (2017-2028) & (MT)
    Figure 33. Global Rheumatoid Arthritis Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Rheumatoid Arthritis Drugs Price by Application (2017-2028) & (USD/Kg)
    Figure 35. United States Rheumatoid Arthritis Drugs Market Share by Application in 2022 & 2028
    Figure 36. United States Rheumatoid Arthritis Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Rheumatoid Arthritis Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Rheumatoid Arthritis Drugs Sales by Application (2017-2028) & (MT)
    Figure 39. United States Rheumatoid Arthritis Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Rheumatoid Arthritis Drugs Price by Application (2017-2028) & (USD/Kg)
    Figure 41. North America Rheumatoid Arthritis Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 42. North America Rheumatoid Arthritis Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Rheumatoid Arthritis Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 46. Europe Rheumatoid Arthritis Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Rheumatoid Arthritis Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 53. Asia-Pacific Rheumatoid Arthritis Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Rheumatoid Arthritis Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 64. Latin America Rheumatoid Arthritis Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Rheumatoid Arthritis Drugs Sales in Volume Growth Rate 2017-2028 (MT)
    Figure 69. Middle East & Africa Rheumatoid Arthritis Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. UAE Rheumatoid Arthritis Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Rheumatoid Arthritis Drugs Value Chain
    Figure 74. Rheumatoid Arthritis Drugs Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed